Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Synbio Tech Inc. (1295:TWSE), powered by AI.
Synbio Tech Inc. is currently trading at $50.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Synbio Tech Inc. on Alpha Lenz.
View Synbio Tech Inc.'s valuation metrics on Alpha Lenz.
“Synbio Tech Inc.'s ROE is 14.6%. Explore profitability and growth together.”
Ask for details →Synbio Tech Inc. is a biotechnology company specializing in the development, research, and manufacturing of probiotic and postbiotic solutions. Established in 2000 and headquartered in Kaohsiung, Taiwan, the company plays a central role in the pharmaceuticals and biotech sector, with a focus on innovative microbial products tailored for both human and animal health. Synbio Tech is recognized for its expertise in lactic acid bacteria, producing a diverse range of products such as lactic acid bacteria powders, starter cultures, fermentation broths, and functional beverages. These are used extensively in functional human health foods, fermented milk drinks, pet nutrition, and as feed additives for livestock and aquaculture—offering sustainable and science-backed alternatives in food production and animal care. With a comprehensive microbial culture collection bank and dedicated microbiome research facilities, Synbio Tech Inc. positions itself as a leader in advancing next-generation probiotic technologies, supporting global food safety and wellness trends across over 30 markets worldwide.
“Synbio Tech Inc.'s ROE is 14.6%. Explore profitability and growth together.”
Ask for details →Synbio Tech Inc. (ticker: 1295) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 50.5 with a P/E ratio of -x and P/B of -x.
ROE is 14.61% and operating margin is 19.10%. Annual revenue is $1.0B.